Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MetAction: Targeted Therapy for Metastatic Cancer
NCT02142036Phase 2Completed
- Sponsor
- Oslo University Hospital
- Start
- May 2014
- Primary completion
- Aug 2018
- Countries
- 1
01
Overview
Phase 2, open-label trial in metastatic cancer, sponsored by Oslo University Hospital. Started May 2014; status: completed.
02
Conditions
metastatic cancer
Beyond the preview
Go deeper on NCT02142036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02142036.